Welcome to our dedicated page for Diebold Nixdorf SEC filings (Ticker: DBD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Diebold Nixdorf, Incorporated (NYSE: DBD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a public company that automates, digitizes and transforms the way people bank and shop, Diebold Nixdorf uses SEC filings to report financial results, material events and changes in executive leadership, among other topics.
Current reports on Form 8-K are a key source of timely information. Diebold Nixdorf files 8-Ks under Item 2.02 to furnish quarterly results of operations and financial condition, typically referencing attached news releases that summarize revenue trends, earnings metrics and free cash flow performance. These filings help investors locate official announcements about quarterly performance and related commentary. The company also uses Item 5.02 of Form 8-K to disclose departures and appointments of certain officers, including changes in roles such as Chief Revenue Officer and Chief Operating Officer, along with references to relevant employment agreements.
In addition to 8-Ks, investors may review the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide more detailed financial statements, segment information for Banking and Retail, and discussions of risk factors and business operations. Proxy statements and related filings can offer insight into executive compensation and governance practices, while Forms 3, 4 and 5 (when filed) provide information on insider share transactions.
On Stock Titan, Diebold Nixdorf filings are complemented by AI-powered summaries that explain the key points of lengthy documents such as 10-Ks and 10-Qs in plain language. Real-time updates from EDGAR help ensure that newly filed 8-Ks, periodic reports and any insider trading forms are quickly available. This allows users to review the regulatory record of DBD and understand how the company communicates financial results, leadership changes and other material information.
Millstreet Capital Management LLC and two principals filed a Form 4 disclosing an insider sale of Diebold Nixdorf common stock. On 09/18/2025 the reporting group sold 38,963 shares at a price of $60.0811 per share. After the transaction the group beneficially owned 5,968,398 shares on an indirect basis. The filing is a joint submission by Millstreet and two managing members, Brian D. Connolly and Craig Kelleher, who state Millstreet advises accounts that hold the reported shares and disclaim direct beneficial ownership except to the extent of their pecuniary interest. The Form shows no derivative positions disclosed.
Millstreet Capital Management LLC and two managing members reported an indirect sale of Diebold Nixdorf (DBD) common stock. On 09/16/2025 the reporting persons disposed of 20,000 shares at $60.1125 per share. After the reported transaction, the group reports beneficial ownership of 6,007,361 shares held indirectly for client accounts. The filing identifies Millstreet as an investment adviser and names Brian D. Connolly and Craig Kelleher as managing members who disclaim beneficial ownership except for their pecuniary interest.